Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer.
BMC cancer 2016 16 (1): 28.
Samulin Erdem Johanna, Skaug Vidar, Bakke Per, Gulsvik Amund, Haugen Aage, Zienolddiny Shanb
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 15, 2019
- Content source: